AirCurve 10 CS PaceWave adaptive servo-ventilator device | ResMed

AirCurve™ 10 CS PaceWave

Adaptive servo-ventilator device

The AirCurve 10 CS PaceWave provides you with personalised ASV* therapy to treat your central sleep apnoea, with or without obstructive sleep apnoea, and promote comfort, safety and harmony while you sleep.

  • aircurve-cs-pacewave-asv-device-front-view-resmed
  • aircurve-cs-pacewave-asv-device-left-view-resmed
  • aircurve-cs-pacewave-asv-device-with-climateline-resmed

ASVAuto mode


ASVAuto mode adapts to your ventilatory and upper airway stability needs on a breath-by-breath basis. By treating breathing disorders with auto-adjusting pressure support and upper airway obstruction with auto-adjusting expiratory positive airway pressure (EPAP), ASVAuto mode rapidly stabilises your respiration.

ASV mode

In the PaceWave ASV mode, the EPAP is manually adjusted by your clinician to set the optimal fixed EPAP to keep your airway open.


Other features

  • Easy-Breathe pressure waveform mimics the wave shape of normal breathing and replicates it for your breathing comfort.
  • Continuous leak management enables reliable delivery of therapy pressure while maintaining patient-device synchrony.
  • Climate Control comprises the optional HumidAir™ humidifier and the optional ClimateLineAir™ heated tube and is designed to deliver constant, comfortable temperature and humidity.

Monitor your sleep apnoea therapy with myAir

Take your new beginning in great sleep to the next level with myAir, an exclusive feature available to users of AirSense 10 and AirCurve 10 devices.**

How to buy

Please contact our Customer Service department or your local representative for more information on obtaining ResMed products.


Please refer to the user guides for relevant information related to any warnings and precautions to be considered before and during use of the products.


*ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnoea.

** With built-in wireless connectivity.